Chengguang Hu

发表

PPP2R5D promotes hepatitis C virus infection by binding to viral NS5B and enhancing viral RNA replication

Yuanping Zhou, Yi-Ping Li, Muhammad Ikram Anwar, 2022, Virology journal.

Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China

Yong-Yuan Zhang, H. Deng, Yuanping Zhou, 2018, Canadian journal of gastroenterology & hepatology.

[Incidence and characteristics of benign liver space-occupying mass in 17 721 patients with chronic hepatitis B: a color Doppler ultrasound-based case-control study].

Yuanping Zhou, Muhammad Ikram Anwar, Yuan Li, 2019, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study

Yong-Yuan Zhang, Dinghua Yang, Yuanping Zhou, 2017, British journal of clinical pharmacology.

Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients with Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience.

Jia Liu, Yong-Yuan Zhang, Yuanping Zhou, 2021, Clinical therapeutics.

A hiddenly high hepatitis C virus related liver disease burden among Chinese patients with non-liver disease complaints: A hospital based study from 2013 to 2017

Yong-Yuan Zhang, Yuanping Zhou, Yi-Ping Li, 2018 .

Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6a

Yong-Yuan Zhang, Tao Wu, Yuanping Zhou, 2017, Cellular Physiology and Biochemistry.

[Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study].

Dinghua Yang, Yuan Li, G. Yuan, 2019, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients

Qifan Zhang, Tao Chen, Yuanping Zhou, 2021, Frontiers in Oncology.

Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication

F. Hu, Xiaoping Tang, Linghua Li, 2020, Emerging microbes & infections.

Serum‑derived hepatitis C virus can infect human glioblastoma cell line SF268 and activate the PI3K‑Akt pathway.

Yong-Yuan Zhang, Yuanping Zhou, Yi-Ping Li, 2019, Molecular medicine reports.

[Depression and anxiety caused by pegylated interferon treatment in patients with chronic hepatitis B and the therapeutic effects of escitalopram and alprazolam].

Yuanping Zhou, Yuan Li, G. Yuan, 2017, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma

Side Liu, Yuanping Zhou, Linlin Zhou, 2022, Frontiers in Oncology.

PPP2R5D Promotes Hepatitis C Virus Infection Through Binding to NS5B Protein

Tao Wu, Yuanping Zhou, Yi-Ping Li, 2021 .

Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy

Yong-Yuan Zhang, Yikai Xu, Jing Zhang, 2021, Frontiers in Oncology.

Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study.

Xiaoping Tang, Yuanping Zhou, Guifang Hu, 2018, Journal of thoracic disease.

Ten‐year follow‐up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon‐α and ribavirin therapy

Y. Huang, K. Shi, Yuanping Zhou, 2016, Journal of viral hepatitis.

Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study

Yikai Xu, Jing Zhang, Yuanping Zhou, 2023, Hepatology International.